» Articles » PMID: 18218157

Pasteurella Multocida and Bovine Respiratory Disease

Overview
Date 2008 Jan 26
PMID 18218157
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Pasteurella multocida is a pathogenic Gram-negative bacterium that has been classified into three subspecies, five capsular serogroups and 16 serotypes. P. multocida serogroup A isolates are bovine nasopharyngeal commensals, bovine pathogens and common isolates from bovine respiratory disease (BRD), both enzootic calf pneumonia of young dairy calves and shipping fever of weaned, stressed beef cattle. P. multocida A:3 is the most common serotype isolated from BRD, and these isolates have limited heterogeneity based on outer membrane protein (OMP) profiles and ribotyping. Development of P. multocida-induced pneumonia is associated with environmental and stress factors such as shipping, co-mingling, and overcrowding as well as concurrent or predisposing viral or bacterial infections. Lung lesions consist of an acute to subacute bronchopneumonia that may or may not have an associated pleuritis. Numerous virulence or potential virulence factors have been described for bovine respiratory isolates including adherence and colonization factors, iron-regulated and acquisition proteins, extracellular enzymes such as neuraminidase, lipopolysaccharide, polysaccharide capsule and a variety of OMPs. Immunity of cattle against respiratory pasteurellosis is poorly understood; however, high serum antibodies to OMPs appear to be important for enhancing resistance to the bacterium. Currently available P. multocida vaccines for use in cattle are predominately traditional bacterins and a live streptomycin-dependent mutant. The field efficacy of these vaccines is not well documented in the literature.

Citing Articles

Antimicrobial Resistance in Isolates from Bovine Mastitis Can Be Associated with Multidrug-Resistance-Mediating Integrative and Conjugative Elements (ICEs).

Jahnen J, Hanke D, Kadlec K, Schwarz S, Kruger-Haker H Antibiotics (Basel). 2025; 14(2).

PMID: 40001397 PMC: 11851858. DOI: 10.3390/antibiotics14020153.


Nasal pathobiont abundance does not differ between dairy cattle with or without clinical symptoms of bovine respiratory disease.

Centeno-Delphia R, Long E, Ellis A, Hofmann S, Mosier K, Ulloa N Anim Microbiome. 2025; 7(1):16.

PMID: 39966965 PMC: 11837595. DOI: 10.1186/s42523-025-00382-3.


Susceptibility of isolated from cattle in Egypt to antibiotics, silver, chitosan and curcumin nanoparticles.

Bahr A, Abdel Massieh E Vet Res Forum. 2024; 15(9):455-462.

PMID: 39564470 PMC: 11571042. DOI: 10.30466/vrf.2024.2017140.4090.


Multi-omics investigation into long-distance road transportation effects on respiratory health and immunometabolic responses in calves.

Qi J, Huang F, Gan L, Zhou X, Gou L, Xie Y Microbiome. 2024; 12(1):242.

PMID: 39548602 PMC: 11568561. DOI: 10.1186/s40168-024-01962-2.


A surface lipoprotein on binds complement factor I to promote immune evasion.

Nguyen Q, Lai C, Norris M, Ng D, Shah M, Lai C bioRxiv. 2024; .

PMID: 39484374 PMC: 11526892. DOI: 10.1101/2024.10.21.619360.